Paper16920175
Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
Burke B and 11 others. Virology, 2006. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies. Papers, record 16920175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16920175
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptation, Biological | Major topic |
| Evolution, Molecular | Major topic |
| HIV Antibodies | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| AIDS Vaccines | |
| Amino Acid Sequence | |
| Amino Acid Substitution | |
| Animals | |
| CD4 Lymphocyte Count | |
| Disease Models, Animal | |
| HIV Envelope Protein gp120 | |
| Macaca mulatta | |
| Molecular Sequence Data | |
| Mutation | |
| Neutralization Tests | |
| RNA, Viral | |
| Receptors, CCR5 | |
| Recombination, Genetic | |
| Selection, Genetic | |
| Simian Immunodeficiency Virus | |
| Viral Load |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 5P01 AI48225-03 | NIAID NIH HHS | United States | P01AI482250 | PubMed | NIH RePORTER |
| AI 55336 | NIAID NIH HHS | United States | R01AI055336 | PubMed and NIH | NIH RePORTER |
| AI-95367 | NIAID NIH HHS | United States | N01AI095367 | PubMed and NIH | NIH RePORTER |
| AI47708 | NIAID NIH HHS | United States | R01AI047708 | PubMed and NIH | NIH RePORTER |
| AI49109 | NIAID NIH HHS | United States | R01AI049109 | PubMed and NIH | NIH RePORTER |
| AI51217 | NIAID NIH HHS | United States | R01AI051217 | PubMed and NIH | NIH RePORTER |
| I-AI-05396 | NIAID NIH HHS | United States | PubMed | PubMed | |
| P01AI048225 | NIH | NIH RePORTER |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26512079 | Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites. | J Virol | 2016 | https://conductscience.org/library/papers/26512079 | PubMed |
| 20354593 | HIV-1 Transmission, Replication Fitness and Disease Progression. | Virology (Auckl) | 2008 | https://conductscience.org/library/papers/20354593 | PubMed |
| 20015987 | Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes. | J Virol | 2010 | https://conductscience.org/library/papers/20015987 | PubMed |
| 19187427 | Differential pathogenicity of SHIV infection in pig-tailed and rhesus macaques. | J Med Primatol | 2008 | https://conductscience.org/library/papers/19187427 | PubMed |
| 18400850 | Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses. | J Virol | 2008 | https://conductscience.org/library/papers/18400850 | PubMed |
| 18003732 | The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous human immunodeficiency virus type 1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen. | J Virol | 2008 | https://conductscience.org/library/papers/18003732 | PubMed |
| 17959660 | Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. | J Virol | 2008 | https://conductscience.org/library/papers/17959660 | PubMed |
| 17683527 | Evolution of naturally occurring 5'non-coding region variants of Hepatitis C virus in human populations of the South American region. | Virol J | 2007 | https://conductscience.org/library/papers/17683527 | PubMed |
| 17560621 | Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens. | Virology | 2007 | https://conductscience.org/library/papers/17560621 | PubMed |
| 17392364 | Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies. | J Virol | 2007 | https://conductscience.org/library/papers/17392364 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCR5 | 1234 | PubTator's text mining | https://conductscience.org/library/genes/1234 | NCBI Gene |
| CXCR4 | 7852 | PubTator's text mining | https://conductscience.org/library/genes/7852 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16920175
GET https://conductscience.org/api/papers/v1/16920175/authors